Participating in the financing were existing investors Claremont Creek Ventures and Sequoia Capital as well as new investor Alafi Capital.
Matthew Rabinowitz, president and CEO of Gene Security Network, said: “The financing from this top syndicate at a high valuation is a testament to the rapid progress we’ve made to deliver accurate testing from a single cell.
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life of their patients.”